中华物理医学与康复杂志
中華物理醫學與康複雜誌
중화물리의학여강복잡지
CHINESE JOURNAL OF PHYSICAL MEDICINE AND REHABILITATION
2014年
6期
416-420
,共5页
陶希%刘佳%邓景贵%宋涛%郑丽君%宋延民%黄洪琳%王淑玲
陶希%劉佳%鄧景貴%宋濤%鄭麗君%宋延民%黃洪琳%王淑玲
도희%류가%산경귀%송도%정려군%송연민%황홍림%왕숙령
经颅磁刺激%低频重复%卒中后抑郁%远期效应%5-羟色胺%日常生活活动
經顱磁刺激%低頻重複%卒中後抑鬱%遠期效應%5-羥色胺%日常生活活動
경로자자격%저빈중복%졸중후억욱%원기효응%5-간색알%일상생활활동
Transcranial magnetic stimulation%Post-stroke depression%5-hydroxytryptamine%Activities of daily living
目的 探讨低频重复经颅磁刺激(rTMS)对卒中后抑郁的远期效应及血浆5-羟色胺(5-HT)表达的影响.方法 选取74例符合本研究标准的脑卒中后抑郁(PSD)患者,按随机数字表法分成对照组(35例)和治疗组(39例).最终资料完整纳入本研究患者65例,对照组31例,治疗组34例.对照组给予舍曲林及基础治疗,治疗组给予低频rTMS及基础治疗,疗程8周.分别于入组前(治疗前)和治疗8周后(治疗后),采用汉密尔顿抑郁量表(HAMD)、中国脑卒中量表(CSS)及改良Barthel指数(MBI)等指标来评定患者的临床抑郁状态、临床神经功能缺损程度及日常生活活动(ADL)能力;以高效液相色谱法检测2组患者治疗前后血浆5-HT浓度.并于12个月后追踪随访(随访时),复测上述指标,进行统计学分析比较.结果 治疗后,2组患者HAMD评分和CSS评分均较治疗前明显下降(P<0.05),MBI评分则较治疗前明显提高(P<0.05);但2组间比较,差异无统计学意义(P>0.05);对照组血浆5-HT浓度较治疗前明显升高(P<0.05),但治疗组变化不明显(P>0.05).12个月后随访时,2组患者HAMD评分和CSS评分均较治疗后进一步下降(P<0.05),MBI评分亦进一步提高(P<0.05);2组间比较,治疗组较对照组HAMD评分下降及MBI评分提高更为显著(P<0.05);2组患者血浆5-HT浓度较治疗后稍高,但差异无统计学意义(P>0.05).治疗后,对照组和治疗组脱离抑郁状态患者分别有10例(32.26%)和12例(35.29%),差异无统计学意义(x2 =0.067,P=0.796),但12个月后随访时,2组脱离抑郁状态患者分别有22例(70.97%)和31例(91.18%),组问差异有统计学意义(x2 =4.399,P=0.036).结论 rTMS治疗可以改善脑卒中后抑郁患者的远期效应,提高患者ADL能力,且其作用机制可能与血浆5-HT表达变化无关.
目的 探討低頻重複經顱磁刺激(rTMS)對卒中後抑鬱的遠期效應及血漿5-羥色胺(5-HT)錶達的影響.方法 選取74例符閤本研究標準的腦卒中後抑鬱(PSD)患者,按隨機數字錶法分成對照組(35例)和治療組(39例).最終資料完整納入本研究患者65例,對照組31例,治療組34例.對照組給予捨麯林及基礎治療,治療組給予低頻rTMS及基礎治療,療程8週.分彆于入組前(治療前)和治療8週後(治療後),採用漢密爾頓抑鬱量錶(HAMD)、中國腦卒中量錶(CSS)及改良Barthel指數(MBI)等指標來評定患者的臨床抑鬱狀態、臨床神經功能缺損程度及日常生活活動(ADL)能力;以高效液相色譜法檢測2組患者治療前後血漿5-HT濃度.併于12箇月後追蹤隨訪(隨訪時),複測上述指標,進行統計學分析比較.結果 治療後,2組患者HAMD評分和CSS評分均較治療前明顯下降(P<0.05),MBI評分則較治療前明顯提高(P<0.05);但2組間比較,差異無統計學意義(P>0.05);對照組血漿5-HT濃度較治療前明顯升高(P<0.05),但治療組變化不明顯(P>0.05).12箇月後隨訪時,2組患者HAMD評分和CSS評分均較治療後進一步下降(P<0.05),MBI評分亦進一步提高(P<0.05);2組間比較,治療組較對照組HAMD評分下降及MBI評分提高更為顯著(P<0.05);2組患者血漿5-HT濃度較治療後稍高,但差異無統計學意義(P>0.05).治療後,對照組和治療組脫離抑鬱狀態患者分彆有10例(32.26%)和12例(35.29%),差異無統計學意義(x2 =0.067,P=0.796),但12箇月後隨訪時,2組脫離抑鬱狀態患者分彆有22例(70.97%)和31例(91.18%),組問差異有統計學意義(x2 =4.399,P=0.036).結論 rTMS治療可以改善腦卒中後抑鬱患者的遠期效應,提高患者ADL能力,且其作用機製可能與血漿5-HT錶達變化無關.
목적 탐토저빈중복경로자자격(rTMS)대졸중후억욱적원기효응급혈장5-간색알(5-HT)표체적영향.방법 선취74례부합본연구표준적뇌졸중후억욱(PSD)환자,안수궤수자표법분성대조조(35례)화치료조(39례).최종자료완정납입본연구환자65례,대조조31례,치료조34례.대조조급여사곡림급기출치료,치료조급여저빈rTMS급기출치료,료정8주.분별우입조전(치료전)화치료8주후(치료후),채용한밀이돈억욱량표(HAMD)、중국뇌졸중량표(CSS)급개량Barthel지수(MBI)등지표래평정환자적림상억욱상태、림상신경공능결손정도급일상생활활동(ADL)능력;이고효액상색보법검측2조환자치료전후혈장5-HT농도.병우12개월후추종수방(수방시),복측상술지표,진행통계학분석비교.결과 치료후,2조환자HAMD평분화CSS평분균교치료전명현하강(P<0.05),MBI평분칙교치료전명현제고(P<0.05);단2조간비교,차이무통계학의의(P>0.05);대조조혈장5-HT농도교치료전명현승고(P<0.05),단치료조변화불명현(P>0.05).12개월후수방시,2조환자HAMD평분화CSS평분균교치료후진일보하강(P<0.05),MBI평분역진일보제고(P<0.05);2조간비교,치료조교대조조HAMD평분하강급MBI평분제고경위현저(P<0.05);2조환자혈장5-HT농도교치료후초고,단차이무통계학의의(P>0.05).치료후,대조조화치료조탈리억욱상태환자분별유10례(32.26%)화12례(35.29%),차이무통계학의의(x2 =0.067,P=0.796),단12개월후수방시,2조탈리억욱상태환자분별유22례(70.97%)화31례(91.18%),조문차이유통계학의의(x2 =4.399,P=0.036).결론 rTMS치료가이개선뇌졸중후억욱환자적원기효응,제고환자ADL능력,차기작용궤제가능여혈장5-HT표체변화무관.
Objective To explore any effect of low-frequency transcranial magnetic stimulation (rTMS) on post-stroke depression and the expression of plasma 5-hydroxytryptamine (5-HT).Methods Seventy-four patients suffering from post-stroke depression (PSD) were divided into a control group (31 cases) which received basic therapy and sertraline and a therapy group (34 cases) which received basic therapy and 8 weeks of low-frequency rTMS.Scores on the Hamihon depression (HAMD) scale and the Chinese stroke scale (CSS) and the modified Barthel index (MBI) were used to evaluate depression,neurological impairment,and ability in the activities of daily living (ADL) before and after the experiment.Levels of plasma 5-HT in the two groups were also detected with high performance liquid chromatography before and after the experiment.The patients were then followed up 1 year later,when these indexes were reassessed.Results After 8 weeks of treatment the HAMD and CSS scores in both groups had decreased significantly,and their MBI scores had increased significantly compared with prior to treatment,but there was no significant difference between the groups.The average plasma 5-HT concentration in the control group had increased significantly,but there was little change in the therapy group.One year later,the HAMD and CSS scores of both groups had declined significantly and their MBI scores had increased further.The average decrease in HAMD scores and rise in MBI scores in the therapy group was significantly greaterthan in the control group.There had been no significant change in plasma 5-HT concentration in either group.After 8 weeks of treatment,10 controls and 12 therapy group patients had escaped depression.A year later the numbers were 22 and 31 cases,a significant inter-group difference.Conclusion Low-frequency rTMS can help alleviate post-stroke depression,and enhance ADL ability.The mechanism might have nothing to do with any change in 5-HT expression.